Article ID Journal Published Year Pages File Type
5158890 European Journal of Medicinal Chemistry 2017 29 Pages PDF
Abstract
Structural optimization of pyrido[2,3-d]pyrimidin-7-ones yielded new selective EGFRT790M inhibitors. Compound 9s exhibited good pharmacokinetic properties with F value of 16%, and inhibited EGFRL858R/T790M kinase and H1975 cells with IC50 values of 2.0 and 40 nM, respectively.191
Related Topics
Physical Sciences and Engineering Chemistry Organic Chemistry
Authors
, , , , , , , , , , ,